Miv Therapeutics, Inc. (IVT) Tops Q2 EPS by 58c

Go back to Miv Therapeutics, Inc. (IVT) Tops Q2 EPS by 58c

InvenTrust Properties Corp. Reports 2022 Second Quarter Results

August 1, 2022 4:15 PM EDT

DOWNERS GROVE, Ill.--(BUSINESS WIRE)-- InvenTrust Properties Corp. (InvenTrust or the Company) (NYSE: IVT) today reported financial and operating results for the period ended June 30, 2022. For the three months ended June 30, 2022 and 2021, Net Income was $41.9 million, or $0.62 per diluted share, compared to Net Income of $1.5 million, or $0.02 per diluted share, respectively.

Second Quarter 2022 Highlights:

NAREIT FFO for the quarter of $0.45 per diluted share Core FFO for the quarter of $0.42 per diluted share Pro Rata Same Property Net Operating Income (NOI) increased 7.7% for the... More